These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 24675137)
1. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins. Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells. Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents. Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway. Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of indolyl chalcones as antitumor agents. Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724 [TBL] [Abstract][Full Text] [Related]
7. ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein. Wang G; Zhan Y; Wang H; Li W Cancer Chemother Pharmacol; 2012 Mar; 69(3):799-805. PubMed ID: 22037880 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones. Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265 [TBL] [Abstract][Full Text] [Related]
9. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity. Farghaly TA; Masaret GS; Muhammad ZA; Harras MF Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic activity of substituted chalcones in terms of molecular electronic properties. Kupcewicz B; Jarzęcki AA; Małecka M; Krajewska U; Rozalski M Bioorg Med Chem Lett; 2014 Sep; 24(17):4260-5. PubMed ID: 25091929 [TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and pro-apoptotic activities of 2'- and 4'-aminochalcones against tumor canine cells. Santos MB; Pinhanelli VC; Garcia MAR; Silva G; Baek SJ; França SC; Fachin AL; Marins M; Regasini LO Eur J Med Chem; 2017 Sep; 138():884-889. PubMed ID: 28738308 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones. Mohamed MF; Hassaneen HM; Abdelhamid IA Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336 [TBL] [Abstract][Full Text] [Related]
13. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship. Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907 [TBL] [Abstract][Full Text] [Related]
14. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer. Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents. Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship. Shenvi S; Kumar K; Hatti KS; Rijesh K; Diwakar L; Reddy GC Eur J Med Chem; 2013 Apr; 62():435-42. PubMed ID: 23395966 [TBL] [Abstract][Full Text] [Related]
17. Antiproliferative activity and p53 upregulation effects of chalcones on human breast cancer cells. Dos Santos MB; Bertholin Anselmo D; de Oliveira JG; Jardim-Perassi BV; Alves Monteiro D; Silva G; Gomes E; Lucia Fachin A; Marins M; de Campos Zuccari DAP; Octavio Regasini L J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1093-1099. PubMed ID: 31117836 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activity of metallic complexes of lawsone. Oramas-Royo S; Torrejón C; Cuadrado I; Hernández-Molina R; Hortelano S; Estévez-Braun A; de Las Heras B Bioorg Med Chem; 2013 May; 21(9):2471-7. PubMed ID: 23545136 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity of some new thieno[2,3-d]pyrimidin-4(3H)-ones containing 1,2,4-triazole and 1,3,4-thiadiazole moiety. Mavrova ATs; Wesselinova D; Tsenov JA; Lubenov LA Eur J Med Chem; 2014 Oct; 86():676-83. PubMed ID: 25222878 [TBL] [Abstract][Full Text] [Related]
20. New Hybrid Scaffolds Based on Carbazole-Chalcones as Potent Anticancer Agents. Rashid F; Zaib S; Ibrar A; Ejaz SA; Saeed A; Iqbal J; Khan I Anticancer Agents Med Chem; 2021; 21(9):1082-1091. PubMed ID: 32698741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]